CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kinarus Therapeutics Holding AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kinarus Therapeutics Holding AG
Technologiepark Basel
Hochbergerstrasse 60C
Phone: +41 616332971p:+41 616332971 BASEL, 4057  Switzerland Ticker: KNRSKNRS
Filed for Bankruptcy on 9/25/2023
On 9/25/2023, Kinarus Therapeutics Holding AG announced its decision to file for Bankruptcy with the Competent Courts in Basel.
Business Summary
Kinarus Therapeutics Holding AG is a Switzerland-based Company that operates as a biopharmaceutical industry engaged in diseases treatment. The Company conducts its work within clinical-stage area and its activities include discovery, examination and development of medicines that are intended for the treatment of viral, respiratory, and ophthalmic diseases. Kinraus therapeutic drug is patent protected KIN001 which is a combination of pamapimod and pioglitazone. KIN0001 offers oral, long-term treatment of diseases with severe impact on the comfort of living.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
4522 Air transportation, nonscheduled
4724 Travel agencies
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HariKumar 67 6/2/2022 6/2/2022
Chief Executive Officer, Vice Chairman of the Board AlexanderBausch 61 6/2/2022 6/2/2022
Interim Chief Financial Officer SubhasisRoy 1/1/2023 6/2/2022
5 additional Officers and Directors records available in full report.

Business Names
Business Name
4M Technologies
4M Technologies Holding
KNRS
PRFN

General Information
Number of Employees: 15 (As of 12/31/2013)
Outstanding Shares: 1,301,777,016 (As of 12/31/2023)
Shareholders: 491
Stock Exchange: SWF
Fax Number: +41 445000801


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024